Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Amgen
Amgen
Amgen puts out welcome mat for Celgene’s Otezla reps, but will they join—and then stay?
Fierce Pharma
Wed, 08/28/19 - 10:58 am
Amgen
Otezla
drug reps
M&A
Six burning Otezla questions
EP Vantage
Tue, 08/27/19 - 10:53 pm
Celgene
Otezla
Amgen
drug pricing
FTC
Tyk2
Bristol-Myers Squibb
Lackluster Amgen, Sanofi PCSK9 drugs could be under major threat from a new rival: analyst
Fierce Pharma
Tue, 08/27/19 - 12:04 pm
Amgen
Regeneron
Sanofi
Praluent
Repatha
Medicines Company
PCSK9 inhibitors
inclisiran
Celgene's $13.4 Billion Deal With Amgen Is a Win-Win-Win
Motley Fool
Mon, 08/26/19 - 10:56 pm
Amgen
Celgene
Otzela
Celgene sells psoriasis pill to Amgen for $13.4 billion, clearing way for close of Bristol merger
Stat
Mon, 08/26/19 - 10:24 am
Amgen
Otezla
Celgene
M&A
Bristol-Myers Squibb
psoriasis
Should Amgen Finally Buy Alexion Pharmaceuticals?
Yahoo/Motley Fool
Sun, 08/25/19 - 05:00 pm
Amgen
Alexion
M&A
Why Alexion Makes Sense As A Target, But Amgen Doesn't As A Buyer
Investors Business Daily
Sat, 08/24/19 - 11:14 am
Amgen
Alexion
M&A
3 Reasons Why Amgen Could Actually Acquire Alexion
Motley Fool
Sat, 08/24/19 - 11:10 am
Alexion
Amgen
M&A
Biotech Giant Amgen Could Be Nearing A Massive Takeover: Report
Investors Business Daily
Thu, 08/22/19 - 05:07 pm
Amgen
Alexion Pharmaceuticals
M&A
Amgen, Allergan biosimilar of Roche's blockbuster Rituxan clears another US pivotal study
Endpoints
Thu, 08/22/19 - 11:54 am
Novartis
Amgen
Allergan
biosimilars
Roches
Rituxan
ABP 798
Amgen biosimilar debut boosted by UnitedHealthcare coverage switch
Biopharma Dive
Mon, 08/19/19 - 11:52 am
insurers
Amgen
biosimilars
Avastin
Herceptin
Roche
UnitedHealthcare
Biopharma's biggest sellers – the oldies that just keep giving
Evaluate Pharma
Sat, 08/17/19 - 01:38 pm
Amgen
Enbrel
patents
biologics
Advair
Zantac
Liptor
Plavix
Novartis’ Sandoz to appeal US district court ruling on biosimilar Erelzi
Pharmaceutical Business Review
Wed, 08/14/19 - 11:13 am
Novartis
Sandoz
biosimilars
Amgen
Enbrel
patents
Erelzi
What Enbrel needs to do after its patent win
EP Vantage
Mon, 08/12/19 - 11:48 am
Amgen
Enbrel
patents
generics
Enbrel ruling lifts Amgen shares
BioCentury
Sat, 08/10/19 - 02:02 pm
Amgen
Enbrel
patents
Sandoz
generics
3 Lung Cancer Stocks That Could Soar in September
Motley Fool
Mon, 08/5/19 - 12:04 am
lung cancer
Eli Lilly
Amgen
AstraZeneca
Amgen results beat estimates, lung cancer trial planned
Yahoo/Reuters
Wed, 07/31/19 - 08:49 am
Amgen
earnings
clinical trials
lung cancer
AMG510
Lilly's Emgality powers ahead with 'best-in-class' CGRP access
Fierce Pharma
Tue, 07/30/19 - 04:21 pm
Eli Lilly
Emgality
migraines
Amgen
Aimovig
Teva Pharmaceutical
Ajovy
AbbVie's Acquisitions Report Card Shows Investors Have a Reason to Worry About the Allergan Buyout
Motley Fool
Sun, 07/21/19 - 04:18 pm
Amgen
Allergan
M&A
Roche doomsday is here: Long-feared Herceptin, Avastin biosims bust into U.S. market
Fierce Pharma
Fri, 07/19/19 - 07:28 pm
Herceptin
Avastin
Roche
biosimilars
Allergan
Amgen
Pages
« first
‹ previous
…
19
20
21
22
23
24
25
26
27
…
next ›
last »